- A tetravalent dengue vaccine developed by the Japanese company Takeda; it is India’s first dengue vaccine.
- It has been approved by the Subject Expert Committee (SEC) under the Drugs Controller General of India (DCGI) for individuals aged 4 to 60 years.
